Related Experiment Video
Updated: May 20, 2025
10:03
Isolation, Propagation, and Identification of Bacterial Species with Hydrocarbon Metabolizing Properties from Aquatic Habitats
Published on: December 7, 2021
3.4K
Engineering Useful Microbial Species for Pharmaceutical Applications.
Amankeldi K Sadanov1, Baiken B Baimakhanova1, Saltanat E Orasymbet1
1LLP "Research and Production Center for Microbiology and Virology", Almaty 050010, Kazakhstan.
Microorganisms
|March 27, 2025
Summary
Microbial engineering advances pharmaceutical biotechnology by optimizing microbes for drug production using tools like CRISPR-Cas and AI. Challenges remain in scaling up, regulation, and biocontainment for sustainable development.
Area of Science:
- Pharmaceutical Biotechnology
- Microbial Engineering
- Synthetic Biology
Background:
- Microbial engineering significantly impacts pharmaceutical biotechnology, enhancing the production of active compounds and therapeutic proteins.
- Advancements in genetic engineering, synthetic biology, and adaptive evolution optimize microbial strains for pharmaceutical applications, improving productivity and stability.
Purpose of the Study:
- To review recent innovations in microbial engineering for pharmaceutical applications.
- To analyze key technological advancements, regulatory challenges, and future perspectives in the field.
Main Methods:
- Utilizing the CRISPR-Cas system for precise genome modification to enhance metabolite biosynthesis and synthetic pathways.
- Applying synthetic biology for targeted microorganism design with improved metabolic efficiency.
- Integrating artificial intelligence (AI) and machine learning (ML) for predicting metabolic interactions and optimizing bioprocesses.
Main Results:
- CRISPR-Cas and synthetic biology accelerate the development of novel drug candidates and enhance therapeutic protein production.
- AI and ML integration optimize bioprocesses and expedite the drug discovery pipeline.
- Key challenges include metabolic pathway optimization, industrial-scale production, regulatory compliance, and biocontainment.
Conclusions:
- Microbial engineering, powered by advanced tools like CRISPR-Cas, synthetic biology, and AI, is revolutionizing pharmaceutical production.
- Addressing challenges in optimization, scalability, regulation, and safety is crucial for future advancements and sustainable industrial application.
